Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 4, 2011, Pages 567-580

  Cantinotti, Massimiliano ^a   Giovannini, Stefania ^a   Murzi, Bruno ^a   Clerico, Aldo ^a,b  

^a G PASQUINUCCI HOSPITAL   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

brain natriuretic peptide (BNP); congenital heart disease; diagnostic accuracy; N terminal proBNP; newborns; pediatric cardiology

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ANGIOGRAPHY; CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART; HEART FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HEART SURGERY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANIMALS; CHILD; HEART DISEASES; HUMANS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 79954497249     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.106     Document Type: Review

References (104)

1. Clerico A, Fontana M, Ripoli A, Emdin M. Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. Adv Clin Chem 2009;48:163-79.
2. Cetin I, Tokel K, Varan B, Orün U, Aşlamaci S. Evaluation of right ventricular function by using tissue Doppler imaging in patients after repair of tetralogy of fallot. Echocardiography 2009;26:950-7.
3. Oosterhof T, Tulevski II, Vliegen HW, Spijkerboer AM, Mulder BJ. Effects of volume and/or pressure overload secondary to con-genital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic res-onance and B-type natriuretic peptide levels. Am J Cardiol 2006; 97:1051-5.
4. Ishii H, Harada K, Toyono M, Tamura M, Takada G. Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot. Am J Cardiol 2005;95:1338-43. (Pubitemid 40719866)
5. Tulevski II, Groenink M, Van Der Wall FF, Van Velduisen DJ, Boomsma F, Stoker J. Increased brain and atrial natriuretic pep-tides in patients with chronic right ventricular overload: cor-relation between plasma neurohormones and right ventricular dysfunction. Heart 2001;86:27-30. (Pubitemid 32977776)
6. Cheung EW, Lam WW, Chiu CS, Chau AK, Cheung SC, Cheung YF. Plasma brain natriuretic peptide levels, right ven-tricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. Int J Cardiol 2007;121:155-62. (Pubitemid 47379452)
7. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, et al. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008;52:114-6.
8. Koch A, Zink S, Singer H, Dittrich S. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection. Eur J Heart Fail 2008;10:60-2.
9. Lechner E, Schreier-Lechner EM, Hofer A, Gitter R, Mair R, Biebl A, et al. Aminoterminal brain-type natriuretic peptide lev-els correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan opera-tion. J Thorac Cardiovasc Surg 2009;138:560-4.
10. Holmgren D, Westerlind A, Berggren H, Lundberg PA, Wah-lander H. Increased natriuretic peptide type B level after the second palliative step in children with univentricular hearts with right ventricular morphology but not left ventricular mor-phology Pediatr Cardiol 2008;29:786-92.
11. Cantinotti M, Storti S, Parri MS, Murzi M, Clerico A. Reference values for plasma B-type natriuretic peptide in the first days of life. Clin Chem 2009;55:1438-40.
12. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-Pro-B-type natriuretic peptide in infants and chil-dren: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8.
13. Cantinotti M, Storti S, Parri MS, Prontera C, Murzi B, Clerico A. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immuno-assay platform. Clin Chem Lab Med 2010;48:697-700.
14. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating conges-tive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004;25:341-6. (Pubitemid 38989517)
15. Ko HK, Lee JH, Choi BM, Lee JH, Yoo KH, Son CS, et al. Utility of the rapid B-type natriuretic peptide assay for detec-tion of cardiovascular problems in newborn infants with res-piratory difficulties. Neonatology 2008;94:16-21. (Pubitemid 351896589)
16. Cantinotti M, Storti S, Ripoli A, Zyw L, Crocetti M, Assanta N, et al. Diagnostic accuracy of B-type natriuretic hormone for congenital heart disease in the first month of life. Clin Chem Lab Med 2010;48:1333-8.
17. Davlouros PA, Karatza AA, Xanthopoulou I, Dimitriou G, Georgiopoulou A, Mantagos S, et al. Diagnostic role of plasma BNP levels in neonates with signs of congenital heart disease. Int J Cardiol 2009 Aug 25. [Epub ahead of print].
18. Law YM, Hoyer AW, Reller MD, Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant car-diovascular disease in children: the Better Not Pout Children! Study J Am Coll Cardiol 2009;54:1467-75.
19. Cantinotti M, Storti S, Crocetti M, Assanta N, Murzi B, Clerico A. Decision levels for plasma B-type natriuretic peptide assay to diagnose significant cardiovascular disease in children. J Am Coll Cardiol 2010;55:1166-7.
20. Cantinotti M, Clerico A, Murzi M, Vittorini S, Emdin M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology Clin Chim Acta 2008;390:12-22.
21. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regula-tion network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290:H17-29.
22. McGrath MF, de Bold AJ. Determinants of natriuretic peptide gene expression. Peptides 2005;26:933-43. (Pubitemid 40725367)
23. Goetze JP. Biosynthesis of cardiac natriuretic peptides. Results Probl Cell Differ 2010;50:97-120.
24. Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay Clin Chem Lab Med 2006;44:366-78.
25. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006;366:304-8. (Pubitemid 43331000)
26. Mir TS, Flato M, Falkenberg J, Haddad M, Budden R, Weil J. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 2006;27:73-7.
27. Mansoub S, Chan MK, Adeli K. Gap analysis of pediatric ref-erence intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006;39:569-87.
28. Koch A, Singer M. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003;89:875-8. (Pubitemid 36920810)
29. Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Bue-low H, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic pep-tide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003;112:896-9. (Pubitemid 37248699)
30. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: reference plasmalevels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004;93: 603-7. (Pubitemid 38570224)
31. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageya-ma M. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003;57:191-7. (Pubitemid 37386876)
32. Rauh M, Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 2003;49:1563-4. (Pubitemid 37011762)
33. Schwachtgen L, Herrmann M, Georg T, Schwarz P, Marx N, Lindinger A. Reference values of NT-proBNP serum concen-trations in the umbilical cord blood and in healthy neonates and children. Z Kardiol 2005;94:399-404. (Pubitemid 40921968)
34. Albers S, Mir TS, Haddad M, Läer S. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability Clin Chem Lab Med 2006;44:80-5. (Pubitemid 43010651)
35. Cohen S, Springer C, Avital A, Perles Z, Rein AJ, Argaman Z, et al. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics 2005;115:1347-50. (Pubitemid 43843242)
36. Hammerer-Lercher A, Mair J, Tews G, Puschendorf B, Sommer R. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 2005;51:913-5. (Pubitemid 40577935)
37. Bakker J, Gies I, Slavenburg B, Bekers O, Delhaas T, van Diei-jen-Visser M. Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood. Clin Chem 2004; 50:2465. (Pubitemid 39552196)
38. Bar-Oz B, Lev-Sagie A, Arad I, Salpeter L, Nir A. N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem 2005;51:926-7. (Pubitemid 40577942)
39. Mannarino S, Ciardelli L, Garofoli F, Perotti G, Mongini E, Damiano S, et al. Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Ital-ian newborns. Early Hum Dev 2009;85:13-7.
40. Mannarino S, Garofoli F, Cerbo RM, Perotti G, Mongini E, Codazzi C, et al. Cord blood, perinatal BNP values in term and preterm newborns. Arch Dis Child Fetal Neonatal Ed 2010; 95:F74.
41. Mannarino S, Garofoli F, Mongini E, Cerbo RM, Codazzi AC, Tzialla C, et al. BNP concentrations and cardiovascular adap-tation in preterm and fullterm newborn infants. Early Hum Dev 2010;86:295-8.
42. Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008;46:748-63. (Pubitemid 351821652)
43. Maffei S, Del Ry S, Prontera C, Clerico A. Increase in circu-lating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin Sci 2001; 101:447-53. (Pubitemid 33032988)
44. Halse KG, Lindegaard ML, Goetze JP, Damm P, Mathiesen ER, Nielsen LB. Increased plasma pro-B-type natriuretic peptide in infants of women with type 1 diabetes. Clin Chem 2005;51: 2296-302. (Pubitemid 41692573)
45. Nybo M, Nielsen LB, Nielsen SJ, Lindegaard M, Damm P, Rehfeld JF, et al. Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with type 1 diabetes. Regul Pept 2007;141:135-9. (Pubitemid 46482700)
46. Hammerer-Lercher A, Puschendorf B, Sommer R, Mair J, Tews G, Shebl O, et al. Natriuretic peptides correlate between new-born twins but not between twins and their mothers. Clin Chim Acta 2007;377:279-80. (Pubitemid 44908248)
47. Kanbe T, Maeno Y, Fujino H, Kanda H, Hirose A, Okada J, et al. Brain-type natriuretic peptide at birth reflects foetal matu-ration and antenatal stress. Acta Paediatr 2009;98:1421-5.
48. Geiger R, Hammerer-Lercher A, Url C, Schweigmann U, Pus-chendorf B, Sommer R, et al. NT-proBNP concentrations indi-cate cardiac disease in pediatric patients. Int J Cardiol 2007; 123:63-5. (Pubitemid 350116965)
49. Hammerer-Lercher A, Geiger R, Mair J, Url C, Tulzer G, Lech-ner E, et al. Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients. Clin Chem 2006;52:1415-9. (Pubitemid 43956035)
50. Sahin M, Portakal O, Karagöz T, Hasçelik G, Ozkutlu S. Diag-nostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem 2010;43:1278-81.
51. Cantinotti M, Vittorini S, Storti S, Prontera C, Murzi M, De Lucia V, et al. Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with con-genital heart diseases. J Cardiovasc Med (Hagerstown) 2009; 10:706-13.
52. Holmgren D, Westerlind A, Lundberg PA, Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging 2005;25:263-9. (Pubitemid 41223528)
53. Koch A, Zink S, Singer H. B-type natriuretic peptide in pae-diatric patients with congenital heart disease. Eur Heart J 2006;27:861-6.
54. Lin NC, Landt ML, Trinkaus KM, Balzer DT, Kort HW, Canter CE. Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol 2005;96:847-50 (Pubitemid 41317663)
55. Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003;45:249-54. (Pubitemid 36995093)
56. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arte-riosus in preterm neonates. J Perinatol 2005;25:709-13. (Pubitemid 41655645)
57. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005;115:255-61.
58. Chen S, Tacy T, Clyman R. How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? J Perinatol 2010;30:780-5.
59. Hsu JH, Yang SN, Chen HL, Tseng HI, Dai ZK, Wu JR. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr 2010;157:79-84.
60. Attridge JT, Kaufman DA, Lim DS. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2009;94:F178-82.
61. Czernik C, Lemmer J, Metze B, Koehne PS, Mueller C, Obla-den M. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008;64:286-90
62. Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Cor-coran JD. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008;93:F257-60. (Pubitemid 352039393)
63. Eerola A, Jokinen E, Boldt T, Pihkala J. The influence of per-cutaneous closure of patent ductus arteriosus on left ventricular size and function: a prospective study using two-and three-dimensional echocardiography and measurements of serum natriuretic peptides. J Am Coll Cardiol 2006;47:1060-6.
64. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005;147:38-42. (Pubitemid 40981143)
65. Paul MA, Backer CL, Binns HJ, Mavroudis C, Webb CL, Yogev R, et al. B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study Pediatr Cardiol 2009;30:1094-7.
66. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002;103:75-7. (Pubitemid 34729127)
67. Holmström H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arterio-sus in preterm infants. Acta Paediatr 2001;90:184-91. (Pubitemid 32222804)
68. Asano K, Kadosawa T, Okumura M, Fujinaga T Peri-operative changes in echocardiographic measurements and plasma atrial and brain natriuretic peptide concentrations in 3 dogs with pat-ent ductus arteriosus. J Vet Med Sci 1999;61:89-91. (Pubitemid 129581173)
69. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25: 336-40. (Pubitemid 38989516)
70. Mir TS, Marohn S, Läer S, Eiselt M, Grollmus O, Weil J. Plas-ma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002;110: e76.
71. Cannesson M, Bionda C, Gostoli B, Raisky O, di Filippo S, Bompard D, et al. Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation. Anesth Analg 2007;104:1059-65. (Pubitemid 46649922)
72. Koch A, Kitzsteiner T, Zink S, Cesnjevar R, Singer H. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int J Cardiol 2007; 114:339-44. (Pubitemid 44855912)
73. Hsu JH, Keller RL, Chikovani O, Cheng H, Hollander SA, Karl TR, et al. B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery J Thorac Cardiovasc Surg 2007;134: 939-45. (Pubitemid 47445583)
74. Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Harmon C, et al. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 2006;131:632-8.
75. Berry JG, Askovich B, Shaddy RE, Hawkins JA, Cowley CG Prognostic value of B-type natriuretic peptide in surgical pal-liation of children with single-ventricle congenital heart disease. Pediatr Cardiol 2008;29:70-5.
76. Hsu JH, Oishi PE, Keller RL, Chikovani O, Karl TR, Azakie A, et al. Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J Thorac Cardiovasc Surg 2008;135:746-53. (Pubitemid 351417935)
77. Walsh R, Boyer C, LaCorte J, Parnell V, Sison C, Chowdhury D, et al. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac sur-gery J Thorac Cardiovasc Surg 2008;135:98-105.
78. Mir TS, Haun C, Lilje C, Läer S, Weil J. Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery. Pediatr Cardiol 2006;27:209-16.
79. Gessler P, Knirsch W, Schmitt B, Rousson V, von Eckardstein A. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 2006;148:372-6.
80. Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, et al. Postoperative course and hemodynamic pro-file after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circu-latory arrest. Circulation 1995;92:2226-35.
81. Niedner MF, Foley JL, Riffenburgh RH, Bichell DP, Peterson BM, Rodarte A. B-type natriuretic peptide: perioperative pat-terns in congenital heart disease. Congenit Heart Dis 2010; 5:243-55.
82. Lindblade CL, Chun DS, Darragh RK, Caldwell RL, Murphy DJ, Schamberger MS. Value of plasma B-type natriuretic pep-tide as a marker for rejection in pediatric heart transplant recip-ients. Am J Cardiol 2005;95:909-11. (Pubitemid 40386814)
83. Lan YT, Chang RK, Alejos JC, Burch C, Wetzel GT. B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 2004;23:558-63. (Pubitemid 38595740)
84. Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poelzl G, Laufer G, et al. B-Type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant 2005;24:1444.e5-1448.e8.
85. Claudius I, Lan YT, Chang RK, Wetzel GT, Alejos J. Use fulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol 2003;92:1368-70. (Pubitemid 37431158)
86. Ationu A, Burch M, Singer D, Littleton P, Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 1993;27:188-9.
87. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children-a three year follow up. Cardiovasc Res 1993;27:2135-9. (Pubitemid 24034725)
88. Yuan SM, Jing H. Palliative procedures for congenital heart defects. Arch Cardiovasc Dis 2009;102:549-57.
89. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F Deanfield JE, Galie N, et al. ESC Guidelines for the manage-ment of grown-up congenital heart disease (new version 2010): the Task Force on the Management of Grown-up Con-genital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2915-57.
90. Neffke JG, Tulevski II, van der Wall EE, Wilde AA, van Veld-huisen DJ, Dodge-Khatami A, et al. ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neu-rohormones and MRI parameters. Heart 2002;88:266-70. (Pubitemid 34913510)
91. Szymański P, Klisiewicz A, Lubiszewska B, Lipczyńska M, Michalek P, Janas J, et al. Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dys-function and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles. Am J Cardiol 2009;104:414-8.
92. Trojnarska O, Gwizdala A, Katarzyński S, Katarzyńska A, Szyszka A, Lanocha M, et al. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic pep-tide in adults with congenital heart disease. Cardiol J 2009; 16:133-41.
93. Koch AM, Zink S, Glöckler M, Seeliger T, Dittrich S. Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair. Int J Cardiol 2010;143:130-4.
94. Cetin I, Tokel K, Varan B, Orün UA, Gökdemir M, Cindik N, et al. Evaluation of right ventricular functions and B-type natriuretic peptide levels by cardiopulmonary exercise test in patients with pulmonary regurgitation after repair of tetralogy of Fallot. J Card Surg 2008;23:493-8.
95. Festa P, Ait-Ali L, Prontera C, De Marchi D, Fontana M, Emdin M, et al. Amino-terminal fragment of pro-brain natriu-retic hormone identifies functional impairment and right ven-tricular overload in operated tetralogy of Fallot patients. Pediatr Cardiol 2007;28:339-45. (Pubitemid 47415600)
96. Norozi K, Buchhorn R, Kaiser C, Hess G, Grunewald RW, Binder L, et al. Plasma N-terminal pro-brain natriuretic pep-tide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest 2005;128: 2563-70. (Pubitemid 41507609)
97. van den Berg J, Strengers JL, Wielopolski PA, Hop WC, Meij-boom FJ, de Rijke YB, et al. Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age. Int J Cardiol 2009;133:364-70.
98. Khositseth A, Manop J, Khowsathit P, Siripornpitak S, Porn-kul R, Lolekha P, et al. N-terminal pro-brain natriuretic pep-tide as a marker in follow-up patients with tetralogy of Fallot after total correction. Pediatr Cardiol 2007;28:333-8. (Pubitemid 47415590)
99. Dodge-Khatami A, Büchel EV, Knirsch W, Kadner A, Rous-son V, Dave HH, et al. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilata-tion. Ann Thorac Surg 2006;82:983-8.
100. Knirsch W, Dodge-Khatami A, Kadner A, Kretschmar O, Steiner J, Böttler P, et al. Assessment of myocardial function in pediatric patients with operated tetralogy of Fallot: prelim-inary results with 2D strain echocardiography Pediatr Cardiol 2008;29:718-25.
101. Norozi K, Buchhorn R, Bartmus D, Alpers V, Arnhold JO, Schoof S, et al. Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of fallot is due to biventricular dysfunction as determined by the myocardial performance index. Am J Cardiol 2006;97: 1377-82.
102. Robbers-Visser D, Kapusta L, van Osch-Gevers L, Strengers JL, Boersma E, de Rijke YB, et al. Clinical outcome 5 to 18 years after the Fontan operation performed on children young-er than 5 years. J Thorac Cardiovasc Surg 2009;138:89-95.
103. Lechner E, Gitter R, Mair R, Pinter M, Schreier-Lechner E, Vondrys D, et al. Aminoterminal brain natriuretic peptide lev-els in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatr Cardiol 2008;29:901-5.
104. Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Com-parison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006;98:520-4. (Pubitemid 44162880)